FITC anti-human CD158 (KIR2DL1/S1/S3/S5) Antibody
- 产品名称:
- FITC anti-human CD158 (KIR2DL1/S1/S3/S5) Antibody
- 产品类别:
- 抗体
- 产品编号:
- 339503
- 产品应用:
- 339503
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
¥ 1212 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- Baboon, Cynomolgus
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Human NK cell clone LB2
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
- Application Notes
mAb HP-MA4 reacts with KIR2DL1 (CD158a), KIR2DS1 (CD158h), KIR2DS3, and KIR2DS5 (CD158g).
Additional reported applications include: inhibits NK cell mediated cytotoxicity and immunoprecipitation.
This clone has been tested in-house and determined to not be suitable for applications in immunohistochemistry of paraffin-embedded tissue sections (IHC-P).
- Application References
(PubMed link indicates BioLegend citation) -
- De Miguel M and M. Lopez-Botet. 2002. Inmunologia. 21:187
- Goodridge JP, et al. 2013. J. Immunol. 191:3553. PubMed
- Product Citations
-
- Hydes T, et al. 2017. Immun Inflamm Dis. 10.1002/iid3.190. PubMed
- Caduff N, et al. 2021. Cell Reports. 35(5):109056. PubMed
- Guo M, et al. 2021. Front Oncol. 11:632540. PubMed
- Mishra HK, et al. 2021. Front Immunol. 12:711621. PubMed
- Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
- Lim D, et al. 2014. J Immunol. 193:5065. PubMed
- Reches A, et al. 2016. J Immunol. 196: 4967 - 4976. PubMed
- Harris LD, et al. 2020. Front Cell Infect Microbiol. 10:120. PubMed
- Goodridge J, et al. 2013. J Immunol. 191:3553. PubMed
- Bennstein SB, et al. 2020. eLife. 9:e55232.. PubMed
- RRID
- AB_1501076 (BioLegend Cat. No. 339503) AB_2130378 (BioLegend Cat. No. 339504)